These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35602292)

  • 1. Long Noncoding RNA HCP5 Contributes to Nasopharyngeal Carcinoma Progression by Targeting MicroRNA-128-3p.
    Miao G; Liu B; Ling K; Peng T; Zhou E; Xie S; Tan Z
    J Oncol; 2022; 2022():5740857. PubMed ID: 35602292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF.
    Liu Y; Wang J; Dong L; Xia L; Zhu H; Li Z; Yu X
    Onco Targets Ther; 2019; 12():8207-8216. PubMed ID: 31632071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer.
    Zhao C; Li Y; Hu X; Wang R; He W; Wang L; Qi L; Tong S
    Onco Targets Ther; 2020; 13():11827-11838. PubMed ID: 33235469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis.
    Bai N; Ma Y; Zhao J; Li B
    Cancer Manag Res; 2020; 12():4747-4758. PubMed ID: 32606965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p.
    Chen S; Ren C; Zheng H; Sun X; Dai J
    Med Sci Monit; 2020 May; 26():e921383. PubMed ID: 32357145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
    Zhao CH; Bai XF; Hu XH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lncRNA HCP5 protects against cerebral ischemia/reperfusion injury by regulating miR-652-3p.
    Gao JD; Li RJ; Ma PL; Yu LL; Li JT; Tian HT
    J Biol Regul Homeost Agents; 2020; 34(3):893-900. PubMed ID: 32657103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.
    Chen Y; Zhang X; An Y; Liu B; Lu M
    Mol Cell Endocrinol; 2020 Mar; 503():110697. PubMed ID: 31891769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis.
    Liu C; Zhang H; Liu H
    Onco Targets Ther; 2019; 12():8455-8466. PubMed ID: 31632090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis.
    Tian X; Liu Y; Wang Z; Wu S
    Biomed Pharmacother; 2020 Nov; 131():110564. PubMed ID: 32920509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HCG11 Facilitates Nasopharyngeal Carcinoma Progression Through Regulating miRNA-490-3p/MAP3K9 Axis.
    Zheng J; Zhao Z; Ren H; Wang Y; Meng X; Zhang W; Zhang C; Ming L; Lu X
    Front Oncol; 2022; 12():872033. PubMed ID: 35463310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.
    Wu Q; Zhao Y; Shi R; Wang T
    Cancer Manag Res; 2021; 13():4103-4114. PubMed ID: 34045897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-141-3p promoted the progression of nasopharyngeal carcinoma through targeting DLC1.
    Mu JW; Zhou XY; Wang QJ; Han LH; Jiao JB
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11105-11113. PubMed ID: 33215427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.